Cabotegravir Suppliers & Bulk Manufacturers
Available Forms: Injection/ Tablet
Available Strengths: 600 mg/3 mL, 30 mg
Reference Brands: Apretude (USA), Vocabria (USA)
Category:
Critical Care
Cabotegravir is a long-acting antiretroviral medication used for HIV-1 prevention (PrEP) and treatment. It works by inhibiting the HIV integrase enzyme, preventing viral replication. Available as oral tablets (Vocabria) for lead-in and intramuscular injections (Apretude, Cabenuva, Rekambys) for maintenance or PrEP, it provides sustained HIV protection or therapy.
Cabotegravir is available in Injection/ Tablet
and strengths such as 600 mg/3 mL, 30 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cabotegravir is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cabotegravir can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing